Predicting risk of type 2 diabetes in England and Wales: Prospective derivation and validation of QDScore

BMJ (Online)

Volumn 338, Issue 7698, 2009, Pages 811-816

  Hippisley Cox, Julia ^a   Coupland, Carol ^a   Robson, John ^b   Sheikh, Aziz ^c   Brindle, Peter ^d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d Avon Primary Care Research Collaborative   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ALGORITHM; ARTICLE; BODY MASS; CALIBRATION; CARDIOVASCULAR DISEASE; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALIDITY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; UNITED KINGDOM;

ADULT; AFRICA; AGE DISTRIBUTION; AGED; ALGORITHMS; ASIA; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; WALES; YOUNG ADULT;

EID: 66849095444     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b880     Document Type: Article

References (61)

1. Hux JE, Bica A, Flintoft V, Ivis F. Population based estimates of the incidence and the prevalence of diabetes in Ontario. Diabetes 2000;49(suppl 1):A388.
2. Bagust A, Hopkinson P, Maslove L, Currie C. The projected health care burden of type 2 diabetes in the UK from 2000 to 2060. Diabet Med 2002;19:1-5.
3. Christakis NA, FowlerJH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007;357:370-9.
4. Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-43.
5. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007;356:213-5.
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
7. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention ormet for min. N Engl J Med 2002;346:393-403.
8. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
9. Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072.
10. Ramachandran A, Snehlatha C, Mary S, Mukesh B, Bhaskar A, Vijay V. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-97.
11. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008;336:1180-5.
12. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007;11(17).
13. Weber MB, Narayan KMV. Diabetes prevention should be a public- health priority. Lancet 2008;371:473-4.
14. Gaziano TA, Galea G, Reddy KS. Scaling up interventions for chronic disease prevention: the evidence.Lancet 2007;370:1939-46.
15. Harris M. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993;16:642-52.
16. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000;16:164-71.
17. Wilson PWF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RBSr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham off spring study. Arch Intern Med 2007;167:1068-74.
18. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical score to predict risk of type two diabetes. Diabetes Care 2003;26:725-31.
19. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borh-Johnsend K. A Danish diabetes risk score for targeted screening: the inter99 study. Diabetes Care 2004;27:727-33.
20. Spijkerman A, Yuyun M, Griffin S, DekkerJ, Nijpels G, Wareham N. The performance of a riskscore as a screening test for undiagnosed hyperglycaemia in ethnic minority groups: data from the 1999 health survey for England. Diabetes Care 2007;27:116-22.
21. Smith JP. Economics of health and mortality special feature: nature and causes oftrends in male diabetes prevalence, undiagnosed diabetes, and the socioeconomic status health gradient. Proc Natl Acad Sci 2007;104:13225-31.
22. Simmons D, Williams DRR, Powell MJ. Prevalence of diabetics in a predominantly Asian community: preliminary findings of the Coventry diabetes study. BMJ 1989;298:18-21.
23. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 2008;94:34-9.
24. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk oftype 2 diabetes: a systematic review and metaanalysis. JAMA 2007;298:2654-64.
25. Hippisley-Cox J, Pringle M. Prevalence, care and outcomes forpatients with diet controlled diabetes in general practice: cross sectional survey. Lancet 2004;364:423-28.
26. Simmons RK, Harding AH, Wareham NJ, Griffin SJ. Do simple questions about diet and physical activity help to identify those at risk oftype 2 diabetes? DiabetMed 2007;24:830-35.
27. Kanaya AM, Fyr CLW, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, etal. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 2005;28:404-8.
28. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction oftype 2 diabetes risk in Japanese Americans. Diabetes Care 2003;26:758-63.
29. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the women's health study. Eur Heart J 2007;28:2937-43.
30. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475-82.
31. Weakliem DL. A critique of the bayesian information criterion for model selection. Sociol Methods Res 1999;27:359-97.
32. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964-74.
33. Gray A, Clarke P, Farmer A, Holman R, United Kingdom Prospective Diabetes Study Group. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). BMJ 2002;325:860.
34. Royston P. Multiple imputation of missing values. StataJ 2004;4:227-41.
35. SchaferJ, Graham J. Missingdata: our view of the state of the art. Psychol Methods 2002;7:147-77.
36. Steyerberg EW, van Veen M. Imputation is beneficial for handling missing data in predictive models. J Epidemiol Community Health 2007;60:979.
37. Moons KGM, Donders RART, Stijnen T, Harrell FJ. Using the outcome for imputation of missing predictor values was preferred. J Epidemiol Community Health 2006;59:1092.
38. Clark T, Altman D. Developing a prognostic model in the presence of missing data: an ovarian cancer case study. J Epidemiol Community Health 2003;56:28-37.
39. Royston P. Multiple imputation of missing values: update of ice. Stata J 2005;5:527-36.
40. Gail M, Pfeiffer R. On evaluating models of absolute risk. Biostatistics 2005;6:227-39.
41. Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Stat Med 1999;18:2529-45.
42. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med 2004;23:723-48.
43. Royston P. Explained variation for survival models. Stata J 2006;6:1-14.
44. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136.
45. Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med 2004;140:689-99.
46. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8-13.
47. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I follow-up study cohort. Lancet 2008;371:923-31.
48. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-81.
49. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005;28:2013-8.
50. Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, RosnerB, et al. Cigarette smoking and the riskof diabetes in women. Am J Public Health 1993;83:211-4.
51. Wild S, MacLeod F, McKnight J, Watt G, MacKenzie C, Ford I, et al. Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study. Diabet Med 2008;25:194-9.
52. Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006;355:375-84.
53. Health survey for England: prevalence of undiagnosed diabetes by age and sex adults aged 35 and over, 2003, England. London: British Heart Foundation, 2003.
54. Health survey for England: the health of minority ethnic groups. Leeds: The Information Centre, 2004 435.
55. Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr. Value of risk stratification to increase the predictive validityofHbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med 2008;23:1346-53.
56. Kumari M, Head J, Marmot M. Prospective study of social and other riskfactorsforincidenceoftype2diabetesintheWhitehallIIstudy. Arch Intern Med 2004;164:1873-80.
57. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86.
58. Townsend P. Deprivation.J Soc Policy 1987;16:125-46.
59. Department of Health. Health survey for England 2004.DH: London, 2004.
60. Rahman M, Simmons R, Harding A, Wareham N, Griffin S. A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 2008;25:191-6.
61. Holt TA, Stables D, Hippisley-Cox J, O'Hanlon S, Majeed A. Identifying undiagnosed diabetes: cross-sectional survey of 3.6 million patients' electronic records. Br J Gen Pract 2008;58:192-6.